Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer.

Saved in:
Bibliographic Details
Title: Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer.
Authors: Gout J; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Perkhofer L; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Morawe M; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Arnold F; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Ihle M; Department of Obstetrics and Gynecology, Ulm University, Ulm, Germany., Biber S; Department of Obstetrics and Gynecology, Ulm University, Ulm, Germany., Lange S; Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technische Universität München, Munich, Germany.; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technische Universität München, Munich, Germany.; Department of Medicine II, Klinikum rechts der Isar, School of Medicine, Technische Universität München, Munich, Germany., Roger E; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Kraus JM; Institute of Medical Systems Biology, Ulm University, Ulm, Germany., Stifter K; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Hahn SA; Department of Molecular GI Oncology, Faculty of Medicine, Ruhr University Bochum, Bochum, Germany., Zamperone A; Department of Surgery, NYU Langone Health, New York, NY, USA.; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA., Engleitner T; Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technische Universität München, Munich, Germany.; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technische Universität München, Munich, Germany., Müller M; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Walter K; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Rodriguez-Aznar E; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Sainz B Jr; Cancer Stem Cell and Tumor Microenvironment Group, Instituto de Investigaciones Biomédicas 'Alberto Sols' CSIC-UAM, Madrid, Spain.; Cancer Stem Cell and Fibroinflammatory Microenvironment Group, Area 3 - Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain., Hermann PC; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Hessmann E; Department of Gastroenterology and Gastrointestinal Oncology, University Medical Center Göttingen, Göttingen, Germany., Müller S; Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technische Universität München, Munich, Germany.; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technische Universität München, Munich, Germany., Azoitei N; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Lechel A; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Liebau S; Institute of Neuroanatomy & Developmental Biology INDB, Eberhard Karls Universitat Tübingen, Tübingen, Germany., Wagner M; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Simeone DM; Department of Surgery, NYU Langone Health, New York, NY, USA.; Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA.; Department of Pathology, NYU Langone Health, New York, NY, USA., Kestler HA; Institute of Medical Systems Biology, Ulm University, Ulm, Germany., Seufferlein T; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany., Wiesmüller L; Department of Obstetrics and Gynecology, Ulm University, Ulm, Germany., Rad R; Institute of Molecular Oncology and Functional Genomics, School of Medicine, Technische Universität München, Munich, Germany.; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technische Universität München, Munich, Germany.; Department of Medicine II, Klinikum rechts der Isar, School of Medicine, Technische Universität München, Munich, Germany.; German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Heidelberg, Germany., Frappart PO; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany.; Institute of Toxicology, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Kleger A; Department of Internal Medicine I, Ulm University Hospital, Ulm, Germany alexander.kleger@uni-ulm.de.
Source: Gut [Gut] 2021 Apr; Vol. 70 (4), pp. 743-760. Date of Electronic Publication: 2020 Sep 01.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: British Medical Assn Country of Publication: England NLM ID: 2985108R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-3288 (Electronic) Linking ISSN: 00175749 NLM ISO Abbreviation: Gut Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-3288
DOI:10.1136/gutjnl-2019-319970